Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP97507.RAvnhR05k7mVHnjHgnFgeXPyZwzHMkC0w0NHZHajpwNaI130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP97507.RAvnhR05k7mVHnjHgnFgeXPyZwzHMkC0w0NHZHajpwNaI130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP97507.RAvnhR05k7mVHnjHgnFgeXPyZwzHMkC0w0NHZHajpwNaI130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP97507.RAvnhR05k7mVHnjHgnFgeXPyZwzHMkC0w0NHZHajpwNaI130_provenance.
- NP97507.RAvnhR05k7mVHnjHgnFgeXPyZwzHMkC0w0NHZHajpwNaI130_assertion description "[ The APOA5 19W variant is associated with increased plasma triglycerides. However, there is no evidence that APOA5 S19W, -12,238T > C, APOA4 T347S and APCC3 -482C > T SNPs are major risk factors of CHD in French men.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP97507.RAvnhR05k7mVHnjHgnFgeXPyZwzHMkC0w0NHZHajpwNaI130_provenance.
- NP97507.RAvnhR05k7mVHnjHgnFgeXPyZwzHMkC0w0NHZHajpwNaI130_assertion evidence source_evidence_literature NP97507.RAvnhR05k7mVHnjHgnFgeXPyZwzHMkC0w0NHZHajpwNaI130_provenance.
- NP97507.RAvnhR05k7mVHnjHgnFgeXPyZwzHMkC0w0NHZHajpwNaI130_assertion SIO_000772 16321685 NP97507.RAvnhR05k7mVHnjHgnFgeXPyZwzHMkC0w0NHZHajpwNaI130_provenance.
- NP97507.RAvnhR05k7mVHnjHgnFgeXPyZwzHMkC0w0NHZHajpwNaI130_assertion wasDerivedFrom gad-20150221 NP97507.RAvnhR05k7mVHnjHgnFgeXPyZwzHMkC0w0NHZHajpwNaI130_provenance.
- NP97507.RAvnhR05k7mVHnjHgnFgeXPyZwzHMkC0w0NHZHajpwNaI130_assertion wasGeneratedBy ECO_0000203 NP97507.RAvnhR05k7mVHnjHgnFgeXPyZwzHMkC0w0NHZHajpwNaI130_provenance.
- gad-20150221 importedOn "2015-02-21" NP97507.RAvnhR05k7mVHnjHgnFgeXPyZwzHMkC0w0NHZHajpwNaI130_provenance.